It is produced through solid-phase peptide synthesis and supplied as a sterile, lyophilized powder for stable storage and consistent laboratory handling
Under normal physiological conditions, a balance exists between pro-oxidant ROS and antioxidants which, on the whole, prevents any damage
Studies that used 1 mg/day in oral and intravenous trials did not show meaningfully better outcomes than lower doses, and higher doses were associated with more reports of headache, diarrhea, and gastrointestinal effects
Nasal mucosa is highly vascularised and allows direct absorption into systemic circulation, though some compound inevitably drains into the throat and undergoes first-pass metabolism
It is available in certain clinics under compounding programs, but quality and consistency can vary widely depending on the source (FDA PCAC briefingcompounding context)